吸入性糖皮质激素可减缓成人哮喘患者的肺功能下降。
Inhaled corticosteroids moderate lung function decline in adults with asthma.
作者信息
Ernst P
出版信息
Thorax. 2006 Feb;61(2):93-4. doi: 10.1136/thx.2005.042010.
Abstract
Further evidence of the benefit of long term inhaled corticosteroids in asthma
摘要
长期吸入皮质类固醇治疗哮喘益处的进一步证据
相似文献
1
Inhaled corticosteroids moderate lung function decline in adults with asthma.吸入性糖皮质激素可减缓成人哮喘患者的肺功能下降。
Thorax. 2006 Feb;61(2):93-4. doi: 10.1136/thx.2005.042010.
2
Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.吸入性糖皮质激素联合阿托伐他汀对特应性哮喘患者肺功能和痰液细胞计数的影响
Thorax. 2008 Dec;63(12):1070-5. doi: 10.1136/thx.2008.100198. Epub 2008 Aug 29.
3
Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.对肺功能迅速下降且有支气管高反应性迹象的受试者早期使用吸入性糖皮质激素进行干预：DIMCA项目的结果
Eur J Gen Pract. 2007;13(2):89-91. doi: 10.1080/13814780701377455.
4
Inhaled corticosteroids and long term outcome in adults with asthma.吸入性糖皮质激素与成人哮喘的长期预后
Thorax. 2006 Nov;61(11):1011. doi: 10.1136/thx.2006.062810.
5
A regular or an intermittent treatment for asthma: the long-term effect.哮喘的常规或间歇性治疗：长期效果。
Eur Rev Med Pharmacol Sci. 2010 Dec;14(12):1037-44.
6
Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE.吸入性类固醇与总IgE升高的哮喘患者肺功能下降减缓相关。
J Allergy Clin Immunol. 2007 Mar;119(3):611-7. doi: 10.1016/j.jaci.2006.11.696. Epub 2007 Jan 25.
7
Inhaled corticosteroids and decline of lung function in community residents with asthma.吸入性糖皮质激素与社区哮喘居民的肺功能下降
Thorax. 2006 Feb;61(2):100-4. doi: 10.1136/thx.2004.037978.
8
A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.一项为期12周的多中心、随机、部分盲法、活性药物对照、平行组研究，旨在评估布地奈德吸入混悬液用于此前使用定量气雾剂或干粉吸入器吸入皮质类固醇治疗的中度至重度持续性哮喘青少年和成人患者的疗效。
Clin Ther. 2007 Jun;29(6):1013-26. doi: 10.1016/j.clinthera.2007.06.005.
9
Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.在患有轻至中度哮喘的成人中，布地奈德/福莫特罗每日一次给药与布地奈德/福莫特罗每日两次给药及布地奈德每日一次给药的比较。
Respir Med. 2006 Dec;100(12):2151-9. doi: 10.1016/j.rmed.2006.03.016. Epub 2006 May 15.
10
Lung function decline in asthma.哮喘患者的肺功能下降
Eur Respir J. 2007 Sep;30(3):411-3. doi: 10.1183/09031936.00080007.
引用本文的文献
1
Asthma progression and mortality: the role of inhaled corticosteroids.哮喘进展和死亡率：吸入性皮质类固醇的作用。
Eur Respir J. 2019 Jul 18;54(1). doi: 10.1183/13993003.00491-2019. Print 2019 Jul.
2
Inhaled corticosteroids and long term outcome in adults with asthma.吸入性糖皮质激素与成人哮喘的长期预后
Thorax. 2006 Nov;61(11):1011. doi: 10.1136/thx.2006.062810.
本文引用的文献
1
Inhaled corticosteroids and decline of lung function in community residents with asthma.吸入性糖皮质激素与社区哮喘居民的肺功能下降
Thorax. 2006 Feb;61(2):100-4. doi: 10.1136/thx.2004.037978.
2
Daily versus as-needed corticosteroids for mild persistent asthma.每日使用与按需使用皮质类固醇治疗轻度持续性哮喘
N Engl J Med. 2005 Apr 14;352(15):1519-28. doi: 10.1056/NEJMoa042552.
3
Progression of asthma measured by lung function in the childhood asthma management program.在儿童哮喘管理项目中通过肺功能测量的哮喘进展情况。
Am J Respir Crit Care Med. 2004 Aug 1;170(3):234-41. doi: 10.1164/rccm.200308-1174OC. Epub 2004 Mar 17.
4
Is airway remodeling clinically relevant in asthma?气道重塑在哮喘中具有临床相关性吗？
Am J Med. 2003 Dec 1;115(8):652-9. doi: 10.1016/j.amjmed.2003.07.010.
5
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial.布地奈德对轻度持续性哮喘的早期干预：一项随机双盲试验
Lancet. 2003 Mar 29;361(9363):1071-6. doi: 10.1016/S0140-6736(03)12891-7.
6
Pharmacotherapy and airway remodelling in asthma?哮喘的药物治疗与气道重塑？
Thorax. 2003 Feb;58(2):163-74. doi: 10.1136/thorax.58.2.163.
7
Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma.吸入性糖皮质激素的常规使用与哮喘住院的长期预防
Thorax. 2002 Oct;57(10):880-4. doi: 10.1136/thorax.57.10.880.
8
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.成人哮喘患者诱导痰分析：识别孤立性痰中性粒细胞增多且对吸入性糖皮质激素反应不佳的亚组。
Thorax. 2002 Oct;57(10):875-9. doi: 10.1136/thorax.57.10.875.
9
Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood.支气管扩张剂后第一秒用力呼气容积/肺活量比值低所表现的哮喘气道重塑的危险因素：一项从儿童期至成年期的纵向人群研究
Am J Respir Crit Care Med. 2002 Jun 1;165(11):1480-8. doi: 10.1164/rccm.2108009.
10
Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.哮喘中的气道炎症、基底膜增厚和支气管高反应性。
Thorax. 2002 Apr;57(4):309-16. doi: 10.1136/thorax.57.4.309.
Zotero 插件